The global pharmaceutical industry's dynamics are shaped by
complex market forces and regulatory environments. Recently, the withdrawal of
pharmaceutical giants from various markets, including Nigeria, has spotlighted the
vulnerabilities in healthcare access and drug availability.
This white paper provides actionable strategies, expert insights, and
real-world case studies.
Expert Insights
Gain valuable perspectives from industry
leaders and healthcare professionals on navigating this complex issue.
Deep Dive into Market Forces
Understand the economic and regulatory factors driving
pharmaceutical exits and their consequences.
Real Case Studies
Get insights from real examples to see what works in the real
world.
Why market leaders are reading the white paper
Here is what some industry experts, policymakers, and organisations are
saying.
“
I learned how rising pharmaceutical production costs impact drug
prices, showing they're not arbitrarily set. One Health excels at measuring and
explaining these effects clearly.
Ose Oyakhilome
Pharmacist
“
This is an eye-opening report on pharma exits in Nigeria. I
learned the critical role of local production in stabilizing drug supply
chains—vital for health organizations.
Emmanuel Purist
Pharma Investor
“
This is really Insightful for Nigerian health organizations
seeking sustainable solutions in the pharma space especially how enhancing local
pharma manufacturing can address drug shortages.
Ola Oladimeji
Senior Pharmaceutical Manager
“
I gained valuable insights from this report. I discovered that
fostering public-private partnerships can significantly mitigate drug shortages and
enhance patient care in Nigerian hospitals.
Dr. Levi Onyema
Medical Doctor & General Practitioner
Get started with OneHealth
Online Pharmacy & Healthcare Solutions
Digital infrastructure for Individuals, Payers &
Providers for easy access to quality medicines & healthcare solutions